Mechanisms of calpain proteolysis following traumatic brain injury: Implications for pathology and therapy: A review and update

Journal of Neurotrauma

Volumn 14, Issue 3, 1997, Pages 121-134

  Kampfl, A ^a   Posmantur, R M ^b   Zhao, X ^c   Schmutzhard, E ^a   Clifton, G L ^c   Hayes, R L ^c  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b PFIZER INC   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

calpain; calpain inhibition; cell death; cytoskeleton; traumatic brain injury

Indexed keywords

AK 295; ALOXISTATIN ACID; CALCIUM; CALPAIN; CALPASTATIN; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; LEUPEPTIN; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEINASE INHIBITOR; UBIQUITIN; UNCLASSIFIED DRUG; [1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER;

BRAIN INJURY; CALCIUM HOMEOSTASIS; ENZYME ACTIVATION; HUMAN; NERVE DEGENERATION; NONHUMAN; PROTEIN DEGRADATION; REVIEW;

EID: 0030951668     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1997.14.121     Document Type: Review

References (137)

1. ARGILES, J., and LOPEZ-SORIANO, J.L. (1996). The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol. Sci. 17, 222-226.
2. BANAY-SCHWARTZ, M., DAHL, D., HUI, K.S., and LAJTHA, A. (1987). The breakdown of the individual neurofilament proteins by cathepsin D. D. Neurochem. Res. 12, 361-367.
3. BANIK N.L., HOGAN E.L., POWERS J.M., and WHETSTINE L. (1982). Degradation of cytoskeletal proteins in experimental spinal cord injury. Neurochem. Res. 7, 1465-1475.
4. BARTUS, R.T., HAYWARD, N.L., ELLIOTT, P.J., et al. (1994). Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of post occlusion intra-arterial administration. Stroke 25, 2265-2270.
5. BARTUS, R.T., ELLIOTT, P.J., HAYWARD, N.L., DEAN, R.L., HARBESON, S.L., STRAUB, J.A., LI, Z., and POWERS, J. (1995a). Calpain as a novel target for treating acute neurological disorders. Neurol. Res. 17, 249-258.
6. BARTUS, R.T., DEAN, R.L., CAVANAUGH, K., EVELETH, D., CARRIERO, D.L., and LYNCH, G. (1995b). Time related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J. Cereb. Blood Flow Metab. 15, 969-979.
7. BLOMGREN, K., MCRAE, A., BONA, L., SAIDO, T.C., KARLSON, J-L., and HAGBERG, H. (1995). Degradation of fodrin and MAP2 after neonatal hypoxic-Ischemia. Brain Res. 684, 136-142.
8. BRORSON, J.R., MARCUCILLI, C.J., and MILLER, R.J. (1995). Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke 26, 1259-1267.
9. CERRETTI, D.P., KOZLOSKY, C.J., MOSLEY, B., NELSON, N., VAN-NESS, K., GREENSTREET, T.A., MARCH, C.J., KRONHEIM, S.R., DRUCK, T., CANNIZZARO, L.A., et al. (1992). Molecular cloning of the interleukin-1 beta converting enzyme. Science 256: 97-100.
10. 2+ level. (in Press).
11. CHIN, T.K., EAGLES, P.A., and MAGGS, A. (1983). The proteolytic digestion of ox neurofilament with trypsin and -chy-motrypsin. Biochem. J. 215, 239-252.
12. CHOI, D.W. (1988). Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation of NMDA antagonists. J. Neurosci. 8, 185-196.
13. 2+-dependent porteinases (μ-calpain and m-calapain). J Biol. Chem. 264, 10096-10103.
14. CRUMRINE, R.C., DUBYAK, G., and LAMANNA, J.C. (1990). Decreased protein kinase C activity during cerebral ischemia and after reperfusion in the adult rat. J. Neurochem. 55, 2001-2007.
15. DASH, P.K., MOORE, A.N., and DIXON, C.E. (1994). Spatial memory deficits, increased phosphorylation of the transcription factor CREB and induction of the AP-1 complex following experimental brain injury. J. Neurosci. 15, 2030-2039.
16. DEL CERRO, S., LARSON, J., OLIVER, M.W., and LYNCH, G. (1990). Development of hippocampal long term potentiation is reduced by recently introduced calpain inhibitors. Brain Res. 530, 91-95.
17. DHERMY, D. (1991). The spectrin super-family. Biol. Cell 71, 249-254.
18. EDMUNDS, T., NAGAINIS, P.A., SATHE, S.K., THOMPSON, V.F., and GOLL, D.E. (1991). Comparison of the autolyzed and unautolyzed forms of μ- and m-calpain from bovine skeletal muscle. Biochim. Biophys. Acta 1077, 197-208.
19. FADEN, A.I., DEMEDIUK, P., PANTER, S.S., and VINK, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 798-800.
20. 45Ca autoradiographic study. Brain Res. 624, 94-102.
21. FRASER, A., and EVAN, G., (1996). A license to kill. Cell 85, 781-784.
22. GAVRIELI, Y., SHERMAN, Y., and BEN-SASSON, S. (1992). Identification of programed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 127, 1717-1727.
23. GEORGE, E.B., GLASS, J.D., and GRIFFIN, J.W. (1995). Axotomy induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neurosci. 15, 6445-6452.
24. GIANCOTTI, F.G., STEPP, M.A., SUZUKI, S., ENGVALL, E., and RUOSLAHTI, E. (1992). Proteolytic processing of endogenous and recombinant beta4 integrin. J. Cell Biol. 118, 951-955.
25. GULTEKIN, S.H., and SMITH, T.W. (1994). Diffuse axonal injury in craniocerebral trauma. A comparative histological and immunohistochemical study. Arch Pathol Lab Med 118, 168-171.
26. HAMAKUBO, T., KANNAGI, R., MURACHI, T., and MATUS, A. (1986). Distribution of calpains 1 and 2 in rat brain. J. Neurosci. 6, 3103-3111.
27. HANSON, S.K., GROTTA, J.C., WAXHAM, M.N., ARONOWSKI, J., and OSTROW, J. (1994). Calcium/calmodulin-dependent protein kinase II activity in focal ischemia with reperfusion in rats. Stroke 25, 466-473.
28. HARRIS, A.S., CROALL, D.E., and MORROW, J.S. (1988). The calmodulin binding site in alpha fodrin is near the calcium-dependent -protease-I cleavage site. J. Biol. Chem. 263, 15754-15761.
29. HAYES, R.L., JENKINS, L.K.W., and LYETH, B.G. (1992). Neurotransmitter-mediated mechanisms of traumatic brain injury. J. Neurotrauma 9, 173-187.
30. HICKS, R., DOUGLAS, S.H., and McINTOSH, T.K. (1995). Temporal response and effects of excitatory amino acid antagonism on microtubule associated protein 2 immunoreactivity following experimental brain injury in rats. Brain Res. 678, 151-160.
31. HIRAI, S., KAWASAKI, H., YANIV, M., and SUZUKI, K. (1991). Degradation of transcription factors c-Jun and c-Fos, by calpain. FEBS Lett. 287, 57-61.
32. HONG, S.C., LAZINO, G., GOTO, S., KANG, S.K., SCHOTTLER, F., KASSELL, N.F., and LEE, K.S. (1994b). Calcium activated proteolysis in rat neocortex induced by transient focal ischemia. Brain Res. 661, 43-50.
33. HONG, S.C., GOTO, Y., LANZINO, G., SOLEAU, S., KASSELL, N.F., and LEE, K.S. (1994a). Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25, 663-669.
34. INUZUKA, T., TAMURA, A., SHUZO, S., KIRINO, T., TOYOSHIMA, I., and MLYATAKE, Y. (1990a). Suppressive effect of E-64 on ischemic degradation of cerebral proteins following occlusion of the middle cerebral artery in rats. Brain Res. 526, 177-179.
35. INUZUKA, T., TAMURA, A., SATO, S., KIRINO, T., TOYOSHIMA, I., and MIYATAKE, T. (1990b). Changes in the concentrations of cerebral proteins following occlusion of the middle cerebral artery in rats. Stroke 21, 917-922.
36. JOHNSON, G.V.W., LITERSKY, J.M., and JOPE, R.S. (1991). Degradation of microtubule-associated protein 2 (MAP2) and brain spectrin by calpain: a comparative study. J. Neurochem. 56, 1630-1638.
37. KAKEGAWA, H., NIKAWA, T., TAGAMI, K., KAMIOKA, H., et al. (1993). Participation of cathepsin L on bone resorption. FEBS Lett 321, 247-250.
38. KAKU, Y., YONEKAWA, Y., TSUKAHARA, T., OGATA, N., KIMURA, T., and TANIGUCHI, T. (1993). Alterations of a 200 kDa neurofilament in the rat hippocampus after forebrain ischemia. J. Cereb. Blood Flow Metab. 13, 402-408.
39. 2+, and its effect on the neurofilament triplet. J. Neurosci. Res. 13, 391-403.
40. KAMPFL, A., ZHAO, X., WHITSON, S.J., POSMANTUR, R., DIXON, C.E., YANG, K., CLIFTON, G.L., and HAYES, R.L. (1996a). Calpain inhibitors protect against depolarization induced neurofilament protein loss of septo-hippocampal neurons in culture. Eur. J. Neurosci. 8, 344-352.
41. KAMPFL, A., POSMANTUR, R., NIXON, R., GRYNSPAN, F., ZHAO, X., LIU, S.J., NEWCOMB, J., CLIFTON, G.L., and HAYES, R. (1996b). μ-Calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J. Neurochem. (in press).
42. KAMPFL, A., WHITSON, S.J., ZHAO, X., POSMANTUR, R., CLIFTON, G.L., and HAYES, R.L. (1995). Calpain inhibitors reduce depolarization induced loss of tau protein in primary septo-hippocampal cultures. Neurosci. Lett. 194, 149-152.
43. KARST, H., JOELS, M., and WADMAN, W.J. (1993). Lowthreshold calcium currents in dendrites of the adult rat hippocampus. Neurosci. Lett. 164, 154-158.
44. KATAYAMA, Y., KAWAMATA, T., TAMURA, T., HOVDA, D.A., BECKER, D.P., and TSUBOKAWA, T. (1991). Calcium-dependent glutamate release concomitant with massive potassium flux during cerebral ischemia in vivo. Brain Res. 558, 136-140.
45. KATAYAMA, Y., BECKER, D.P., TAMURA, T., and HOVDA, D.A. (1990). Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J. Neurosurg. 73, 889-900.
46. KATUNUMA, N. (1994). Participation of lyposomal cathepsins in antigen processing and bone absorption, in Biological Functions of Proteases and Inhibitors. N. Katunuma, K. Suzuki, J. Travis, and H. Fritz (eds.). Scientific Press: Japan. pp. 3-22.
47. KERR, J.F.R., and HARMON, B.V. (1991). Definition and incidence of apoptosis: an historical perspective of apoptosis, in The Molecular Basis of Cell Death. L.D. Tomei and F.O. Capo (eds.) Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, p. 5.
48. KITAGAWA, K., MASTUMOTO, M., NINOBE, M., et al. (1989). Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage-immunohistochemical investigation of dendritic damage. Neuroscience, 31, 401-411.
49. KOGA, H., MORI, N., YAMADA, H., NISHIMURA, Y., TOKUDA, K., KATO, K., and IMOTO, T. (1992). Endo- and aminopeptidase activities of rat cathepsin H. Chem. Pharm. Bull. 40, 965-970.
50. LAZENBIK, Y.A., KAUFMAN, S.H., DESNOYERS, POIRIER, G.G., and EARNSHAW, W.C. (1994). Cleavage of poly (ADP-Ribosome) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
51. LEE, K.S., FRANK, S., VANDERKLISH, P., ARAI, A., and LYNCH G. (1991). Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc. Natl. Acad. Sci. USA. 88, 7233-7237.
52. LI, Z., and BANIK, N.L. (1995). The localization of mcalpain in myelin: immunocytochemical evidence in different areas of rat brain and nerves. Brain Res. 697, 112-121.
53. LUDIN, P., and MATUS, A. (1993). The neuronal cytoskeleton and its role in axonal and dendritic plasticity. Hippocampus 3, 61-71.
54. 2 protein by purified bovine brain multicatalytic proteinase complex (MPC). Neurochemical Res. 17(12), 1261-1266.
55. 2+ activated +ATP-ubiquinated-dependent proteolytic pathways in skeletal muscle from head trauma patients. P.N.A.S. 93, 2714-2718.
56. MARTIN, S.J., O'BRIEN, G.A., NISHIOKA, W.K., MCLAHON, A.J., MAHBOUBIN, T., SAIDO, T.C., and GREEN, D. (1995). Proteolysis of fodrin during apoptosis. J. Biol. Chem. 270, 6425-6428.
57. MATESIC, D.F., and LIN, R.C.S. (1994). Microtubule associated protein 2 as an early indicator of ischemia induced neurodegeneration in the gerbil forebrain. J. Neurochem. 63, 1012-1020.
58. MATSUNAGA, Y., SAIBARA, T., TAGAMI, K., KAMIOKA, H. et al. (1993). Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett 324, 325-330.
59. McINTOSH, T.K. (1993). Novel pharmacological therapies in the treatment of experimental brain injury. A review. J. Neurotrauma 10, 215-261.
60. McINTOSH, T.K., SMITH, D.H., and GARDE, E. (1996). Therapeutic approaches for the prevention of secondary brain injury. Europ. J. of Anaes. 13, 291-309.
61. MELLGREN, R.L., and MURACHI, T. (1990). In Intracellular calcium dependent proteolysis. R.L. Mellgren and T. Murachi (eds.) Boca Raton, FL: CRC Press, pp. 1-288.
62. MELLONI, E., and PONTREMOLI, S. (1989). The calpains. Trends Neurosci. 12, 438-444.
63. MIYAZAKI, S., KATAYAMA, Y., LYETH, B.G., and HAYES, R.L. (1992). Enduring suppression of hippocampal long-term potentiation following traumatic brain injury in rat. Brain Res. 585, 335-339.
64. 2+/calmodulin-dependent protein kinase II and calcineurin in the hippocampus of rat brain after transient forebrain ischemia. J. Neurochem. 58, 1798-1809.
65. NADLER, V., BIEGON, A., BETI-YANNAI, E., ADAMCHIK, J., and SHOHAMI, E. (1995). Ca accumulation in rat brain after closed head injury: attentuation by the novel neurorpotective agent HU-211. Brain Res. 685, 1-11.
66. NAKAMURA, M., ARAKI, M., OGURO, K., and MASUZAWA, T. (1992). Differential distribution of 68kD and 200kD neurofilament proteins in gerbil hippocampus and their early distributional changes following transient forebrain ischemia. Exp. Brain Res. 89, 31-39.
67. NATH, R., RASER, K., STAFFORD, D., HAJIMOHAMMADREZA, II, POSNER, A., ALLEN, H., TALANIAN, R.V., YUEN, P.W., GILBERTSEN, B., and WANG, K.K.W. (1996a). α-spectrin breakdown by calpain and ICE-like proteases in apoptotic celldeath: contributory roles of both proteases families in neuronal apoptosis. Biochemical J. 319, 683-690.
68. NATH, R., RASER, K.J., MCGINNIS, K., NADIMPALL, R., STAFFORD, D., and WANG, K.K.W. (1996b). Effects of ICE-like protease and calpain inhibitors on neuronal apoptosis. NeuroReport, in press.
69. NEUMAR, R.W., HAGLE, W.M., DEGARCIA, D.J., KRAUSE, G.S., and WHITE, B.C. (1996). Brain μ-calpain autolysis during global cerebral ischemia. J. Neurochem. 66, 421-424.
70. NICHOLSON, D.W., AMBEREEN, A.N., THORNBERRY, N.A., VALLANCOURT, J.P. et al. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
71. 2+ levels following cortical compression trauma in rats. J. Cereb. Blood Flow Metab. 13, 183-192.
72. NISHIDA, A., EMOTO, K., SHIMIZU, M., UOZUMI, T., and YAMAWAKI, S. (1994). Brain ischemia decreases phophatidylcholine-phospholipase D but not phosphatidylinositol-phospholipase C in rats. Stroke 25, 1247-1251.
73. NIXON, R.A., and SIHAG, R.K. (1991). Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci. 14, 501-506.
74. NIXON, R.A., and MAROTTA, C.A. (1984). Degradation of neurofilament proteins by purified human brain cathepsin D. J. Neurochem. 43, 507-516.
75. NIXON, R.A. (1989). Calcium activated neutral proteinases as regulators of cellular function. Implications for Alzheimers disease pathogenesis. Ann. N.Y. Acad. Sci. 568, 198-208.
76. OSTWALD, K., HAYASHI, M., NAKAMURA, M., and KAWASHIMA, S. (1994). Subcellular distribution of calpain and calpastatin immunoreactivity and fodrin proteolysis in rabbit hippocampus after hypoxia and glucocorticoid treatment. J. Neurochem. 63, 1069-1076.
77. PERLMUTTER, L.S., SIMAN, R., GALL, C., SEUBERT, P., BAUDRY, M., and LYNCH, G. (1988). The ultrastructural localization of calcium activated protease "Calpain" in rat brain. Synapse 2, 79-88.
78. PERLMUTTER, L.S., GALL, C., BAUDRY, M., and LYNCH, G. (1990). Distribution of calcium-activated protease in the rat brain. J. Comp. Neurol. 296, 269-276.
79. PETTUS, E.H., CHRISTMAN, C.W., GIEBEL, M.L., and POVLISHOCK, J.T. (1994). Traumatically induced altered membrane permeability: Its relationship to traumatically induced reactive axonal change. J. Neurotrauma 11, 507-521.
80. PETTUS, E.H., and POVLISHOCK, J.T. (1996). Characterization of a disstinct set of intra-axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability. Brain Research 722, 1-11.
81. POSMANTUR, R., HAYES, R.L., DIXON, C.E., and TAFT, W.C. (1994). Neurofilament 68 and neurofilament 200 protein levels decrease after traumatic brain injury. J. Neurotrauma 11, 533-545.
82. POSMANTUR, R.M., KAMPFL, A., LIU, S.J., HECK, K., TAFT, W.C., CLIFTON, G.L., and HAYES, R.L. (1996a). Cytoskeletal derangements of cortical neuronal processes three hours after traumatic brain injury in rats: an immunofluorescence study. J. Neuropath. Exp. Neurol. 55, 68-90.
83. POSMANTUR, R., KAMPFL, A., TAFT, W.C., BHATTACHARJEE, M., DIXON, C.E., BAO, J., and HAYES, R.L. (1996b). Diminished microtubule associated protein 2 immunoreactivity following cortical impact injury. J. Neurotrauma 13, 125-137.
84. POSMANTUR, R., KAMPFL, A., SIMAN, R., LIU, S.J., ZHAO, X., CLIFTON, G.L., and HAYES, R.L. (1996c). A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience, in press.
85. POSMANTUR, R.M., ZHAO, X., KAMPFL, A., LIU, J.S., CLIFTON, G.L., and HAYES, R.L. (1996d). A one and two-dimensional immunoblot analyses of putative calpain medicated neurofilament BDPs following traumatic brain injury in rats. Soc. for Neurosci. 22, 1903.
86. POVLISHOCK, J.T., and CHRISTMAN, C.W. (1995). The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts. J. Neurotrauma 12, 555-564.
87. POVLISHOCK, J.T., MARMAROU, A., McINTOSH, T., TROJANOWSKI, J.Q., and MOROI, J. (1996). Impact acceleration injury in the rat: evidence for focal axolemmal change and related neurofilament sidearm alteration. J. Neuropathol. & Experiment. Neurol. (in press).
88. RAMI, A., and KRIEGLSTEIN, J. (1993). Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res. 609, 67-70.
89. REEVES, T.M., LYETH, B.G., and POVLISHOCK, J.T. (1995). Long-term potentiation deficits and excitability changes following traumatic brain injury. Exp. Brain Res. 106, 248-256.
90. REGEHR, W.G., and TANK, D.W. (1994). Dendritic calcium dynamics. Curr. Opin. Neurobiol. 4, 373-382.
91. RINK, A., FUNG, K.M., TROJANOWSKI, J.Q., LEE, V.M.Y., MEUGEBAUER, E., and McINTOSH, T.K. (1995). Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am. J. Pathol. 147, 1575-1583.
92. ROBERTS-LEWIS, J.M., SAVAGE, M.J., MARCY, V.R., PINSKER L.R., and SIMAN, R. (1994). Immunolocalization of calpain 1 mediated spectrin degradation to vulnerable neurons in ischemic gerbil brain. J. Neurosci. 14, 3934-3944.
93. ROBINSON, A. (1996). Inhibiting calpain, rescuing cells. Can. Med. Assoc. J. 154, 193-195.
94. ROSENBERG, G. (1995). Matrix metalloproteinases in brain injury. J. Neurotrauma 12, 833-840.
95. ROTHMAN, S.M., and OLNEY, J.W. (1995). Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci. 18, 57-58.
96. SAATMAN, K.E., BOZYCZKO-COYNE, D., SIMAN, R., MARCY V., and, T.K. (1996a). Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 55, 852-862.
97. SAATMAN, K.E., MURAI, H., BARTUS, R.T., SMITH, D.H., HAYWARD, N.J., PERRI, B.R., and McINTOSH, T.K. (1996b). Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc. Natl. Acad. Sci. USA. 93, 3428-3433.
98. SAIDO, T.C., SORIMACHI, H., and SUZUKI, K. (1994). Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8, 814-822.
99. SAIDO, T.C., NAGAO, S., SHIRAMINE, M., TSUKAGUCHI, M., SORIMACHI, H., MUROFUCSHI, H., TSUCHCHIYA, T., ITO, H., and SUZUKI K. (1992). Autolytic transition of μ-calpain upon activation as resolved by antibodies distinguishing between pre- and post-autolysis forms. J. Biochem. 111, 81-86.
100. SAIDO, T.C., SHUBATA, M., TAKENAWA, T., MUROFUSH, H., SUZUKI, K. (1992). Positive regulation of μ-calpain action by polyphosphoinositides. J. Biol. Chem. 264(34), 24585-24590.
101. SAIDO, T.C., SUZUKI, H., YAMAZAKI, H., TANOUE, K., and SUZUKI, K. (1993a). In situ capture of μ-calpain activation in platelets. J. Biol. Chem. 268, 7422-7426.
102. SAIDO, T.C., YOKOTA, M., NAGAO, S., et al. (1993b). Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 33, 25239-25243.
103. SAITO, K.I., ELCE, J.S., HAMOS, J.E., and NIXON, R.A. (1993). Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. USA. 90, 2628-2632.
104. SAKAI, H., SAKU, T., KATO, Y., and YAMAMOTO et al. (1989). Quantitation and immunohistochemical localization of cathepsins E and D in rat tissues and blood cells. Biochim Biophys Acta 991, 367-375.
105. SCHLAEPFER, W. (1987). Neurofilaments: Structure, metabolism, and implications in disease. J. Neuropath. Exp. Neurol. 46, 117-129.
106. SCHLAEPFER, W.W., and ZIMMERMAN, U.J. (1985). Mechanisms underlying the neuronal response to ischemic injury. Calcium-activated proteolysis of neurofilaments. Prog. Brain Res. 63, 185-196.
107. SCHLAEPFER, W.W., LEE, C., LEE, V.W., and ZIMMERMAN, U.J. (1985). An immunoblot study of neurofilament degradation in situ and during calcium activated proteolysis. J. Neurochem. 44, 502-509.
108. SEUBERT, P., LEE, K., and LYNCH, G. (1989). Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res. 492, 366-370.
109. SHAPIRA, Y., YADID, G., COTEX, S., and SHAHOAMI, E. (1989). Accumulation of calcium in the brain following head trauma. Neurological Res. 11, 169-172.
110. SHAW, G. (1986). Neurofilaments: Abundant but mysterious structures. Bioessays 4, 161-166.
111. SIESJOE, B.K., and BENGTSSON F. (1989). Calcium fluxes, calcium antagonists, and calcium related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9, 127-140.
112. SIMAN, R., BAUDRY, M., and LYNCH, G. (1984). Brain fodrin: Substrate for calpain 1, an endogenous calcium-activated protease. Proc. Natl. Acad. Sci. USA. 81, 3572-3575.
113. SIMAN, R., and NOSZEK, J.C. (1988). Excitatory amino acids activate calpain 1 and induce structural protein breakdown in vivo. Neuron 1, 279-287.
114. SIMAN, R., NOSZEK, J.C., and KEGERISE, C. (1989). Calpain 1 activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9, 1579-1590.
115. SORIMACHI, H., SAIDO, T.C., and SUZUKI, K. (1994). New era of calpain research: Discovery of tissue-specific calpains. FEBS Ltrs 343, 1-5.
116. SQUIER, M.K.T., MILLER, A.C.K., MALKINSON, A.M., and COHEN, J.J. (1994). Calpain activation in apoptosis. J. Cell. Physiol. 159, 229-237.
117. SUZUKI, K., SORIMACHI, H., YOSHIZAWA, T., KINBARA, K., and ISHIURA, S. (1995). Calpain: novel family members, activation and physiological function. Biol. Chem. Hoppe-Seyler 376, 523-529.
118. SUZUKI, H., TAKEDA, M., NAKAMURA, Y., KATO, Y., TADA, K., HARIGUCHI, S., and NISHIMURA, T. (1984). Neurofilament degradation by bovine brain cathepsin D. Neurosci Lett 89, 240-245.
119. SZATKOWSKI, M., and ATWELL, D. (1994). Triggering and execution of neuronal death in brain ischemia: two phases of glutamate release by different mechanisms. Trends Neurosci. 17, 359-365.
120. TAFT, W.C., YANG, K., DIXON, C.E., and HAYES, R.L. (1992). Microtubule associated protein 2 level in hippocampus following traumatic brain injury. J. Neurotrauma 9, 281-290.
121. TAFT, W.C., YANG, K., DIXON, C.E., CLIFTON, G.L., and HAYES, R.L. (1993). Hypothermia attenuates the loss of hippocampal microtubule-associated protein 2 (MAP2) following traumatic brain injury. J. Cereb. Blood. Flow. Metab. 13, 796-802.
122. TEWART, M., QUAN, L., O'ROURKE, K., DESNOYERS, S., ZENG, Z., BEIDLER, D., POIRIER, G., SALVESEN, G., and DIXIT, V.M. (1995). Yama/CPP32B, a mammalian homolog of CED-3, is a CmA-inhibitable protease that cleaves the death substrate Poly (ADP-Ribose) Polymerase. Cell 81, 801-809.
123. THORNBERRY, N.A., BULL, H.G., CALAYCAY, J.R., CHAPMAN, K.T., HOWARD, A.D., KOSTURA, M.J., MILLER, D.K., MOLINEAUX, S.M., WEIDNER, J.R., AUNINS, J. et al. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768-774.
124. VAUX, D.L., and STRASSER, A. (1996). The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93, 2239-2244.
125. WANG, K.K.W., VILLALOBO, A., and ROUFOGALIS, B.D. (1989). Calmodulin-binding proteins as calpain substrates. Biochem J. 262, 693-706.
126. WANG, K.K.W., and YUEN, P.-W. (1994). Calpain inhibition: An overview of its therapeutic potential. Trends. Pharmacol. Sci. 15, 412-419.
127. WHITSON, J.S., KAMPFL, A., ZHAO, X., DIXON, C.E., and HAYES, R.L. (1995a). Brief potassium depolarization decreases levels of neurofilament proteins in CNS culture. Brain Res. 694, 213-222.
128. WHITSON, J.S., KAMPFL A., ZHAO, X., and HAYES, R.L. (1995b). Transient loss of neurofilament proteins following brief potassium depolarization in CNS culture. Neurosci. Lett. 197, 159-163.
129. WIELOCH, T., CARDELL, M., BINGREN, H., ZIVIN, J., and SAITOH, T. (1992). Changes in the activity of protein kinase C and the differential subcellular redistribution of its isoenzymes in the rat striatum during and following transient forebrain ischemia. J. Neurochem. 56, 1227-1233.
130. YAGHMAI, A., and POVLISHOCK, J. (1992). Traumatically induced reactive change as visualized through the use of monoclonal antibodies targeted to neurofilament subunits. J. Neuropath. Exp. Neurol. 51, 158-176.
131. YAMAMOTO, K., SAKAI, H., UENO, E., and KATO, Y. (1991). Structure and function of the aspartic proteinases. B.M. Dunn (Ed). New York: Plenum Press, 207-306.
132. YAMASAKI, Y., ONODERA, H., ADACHI, K., SHOZUHARA, H., and KOGURE, K. (1992). Alteration in the immunoreactivity of the calcineurin subunits after ischemia hippocampal damage. Neuroscience 49, 545-556.
133. YANG, K.Y., TAFT, W.C., DIXON, C.E., YU, R.K., and HAYES, R.L. (1994). Endogenous phosphorylation of a 61000 dalton hippocampal protein increases following TBI. J. Neurotrauma 11, 523-532.
134. YUEN, P.-W., and WANG, K.K.W. (1996). Therapeutic potential of calpain inhibitors in neurodegeneerative disorders. Exp. Opin. Invest. Drugs 5(10), 1291-1304.
135. YUSTE, R., GUTNICK, M.J., SAAR, D., DELANEY, K.R., and TANK, D.W. (1994). Calcium accumulations in dendrites of neocortical pyramidal neurons: an apical band and evidence for two functional compartments. Neuron 13, 23-43.
136. ZHANG, W., LANE, R.D., MELLGRAN, R.L. (1996). The Major Calpain Isozymes Are Long-lived Proteins. J Biological Chem, (271) 31, 18825-18830.
137. ZIMMERMAN, U.J.P., and SCHLAEPFER, W.W. (1991). Two stage autolysis of the catalytic subunit inititates autolysis of μ-calpain. Biochem. Biophys. Acta. 1078, 192-198.